Report Detail
Global Choroidal Neovascularization Market Insights, Forecast to 2025
- RnM3447442 |
- 22 May, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Other
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.
The global Choroidal Neovascularization market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Choroidal Neovascularization market based on company, product type, end user and key regions.
This report studies the global market size of Choroidal Neovascularization in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Choroidal Neovascularization in these regions.
This research report categorizes the global Choroidal Neovascularization market by top players/brands, region, type and end user. This report also studies the global Choroidal Neovascularization market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Valeant Pharmaceuticals International Inc.
Gilead Sciences Inc
Market size by Product
Intravenous
Intravitreal
Market size by End User
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Choroidal Neovascularization market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Choroidal Neovascularization market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Choroidal Neovascularization companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Choroidal Neovascularization submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Choroidal Neovascularization are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Choroidal Neovascularization market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Choroidal Neovascularization Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Choroidal Neovascularization Market Size Growth Rate by Product
- 1.4.2 Intravenous
- 1.4.3 Intravitreal
- 1.5 Market by End User
- 1.5.1 Global Choroidal Neovascularization Market Size Growth Rate by End User
- 1.5.2 Extreme Myopia
- 1.5.3 Malignant Myopic Degeneration
- 1.5.4 Age-Related Developments
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Choroidal Neovascularization Market Size
- 2.1.1 Global Choroidal Neovascularization Revenue 2014-2025
- 2.1.2 Global Choroidal Neovascularization Sales 2014-2025
- 2.2 Choroidal Neovascularization Growth Rate by Regions
- 2.2.1 Global Choroidal Neovascularization Sales by Regions
- 2.2.2 Global Choroidal Neovascularization Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Choroidal Neovascularization Sales by Manufacturers
- 3.1.1 Choroidal Neovascularization Sales by Manufacturers
- 3.1.2 Choroidal Neovascularization Sales Market Share by Manufacturers
- 3.1.3 Global Choroidal Neovascularization Market Concentration Ratio (CR5 and HHI)
- 3.2 Choroidal Neovascularization Revenue by Manufacturers
- 3.2.1 Choroidal Neovascularization Revenue by Manufacturers (2014-2019)
- 3.2.2 Choroidal Neovascularization Revenue Share by Manufacturers (2014-2019)
- 3.3 Choroidal Neovascularization Price by Manufacturers
- 3.4 Choroidal Neovascularization Manufacturing Base Distribution, Product Types
- 3.4.1 Choroidal Neovascularization Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Choroidal Neovascularization Product Type
- 3.4.3 Date of International Manufacturers Enter into Choroidal Neovascularization Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Choroidal Neovascularization Sales by Product
- 4.2 Global Choroidal Neovascularization Revenue by Product
- 4.3 Choroidal Neovascularization Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Choroidal Neovascularization Breakdown Data by End User
6 North America
- 6.1 North America Choroidal Neovascularization by Countries
- 6.1.1 North America Choroidal Neovascularization Sales by Countries
- 6.1.2 North America Choroidal Neovascularization Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Choroidal Neovascularization by Product
- 6.3 North America Choroidal Neovascularization by End User
7 Europe
- 7.1 Europe Choroidal Neovascularization by Countries
- 7.1.1 Europe Choroidal Neovascularization Sales by Countries
- 7.1.2 Europe Choroidal Neovascularization Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Choroidal Neovascularization by Product
- 7.3 Europe Choroidal Neovascularization by End User
8 Asia Pacific
- 8.1 Asia Pacific Choroidal Neovascularization by Countries
- 8.1.1 Asia Pacific Choroidal Neovascularization Sales by Countries
- 8.1.2 Asia Pacific Choroidal Neovascularization Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Choroidal Neovascularization by Product
- 8.3 Asia Pacific Choroidal Neovascularization by End User
9 Central & South America
- 9.1 Central & South America Choroidal Neovascularization by Countries
- 9.1.1 Central & South America Choroidal Neovascularization Sales by Countries
- 9.1.2 Central & South America Choroidal Neovascularization Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Choroidal Neovascularization by Product
- 9.3 Central & South America Choroidal Neovascularization by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Choroidal Neovascularization by Countries
- 10.1.1 Middle East and Africa Choroidal Neovascularization Sales by Countries
- 10.1.2 Middle East and Africa Choroidal Neovascularization Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Choroidal Neovascularization by Product
- 10.3 Middle East and Africa Choroidal Neovascularization by End User
11 Company Profiles
- 11.1 Pfizer Inc.
- 11.1.1 Pfizer Inc. Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Inc. Choroidal Neovascularization Products Offered
- 11.1.5 Pfizer Inc. Recent Development
- 11.2 F. Hoffmann-La Roche Ltd.
- 11.2.1 F. Hoffmann-La Roche Ltd. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Products Offered
- 11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
- 11.3 Novartis AG
- 11.3.1 Novartis AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis AG Choroidal Neovascularization Products Offered
- 11.3.5 Novartis AG Recent Development
- 11.4 Regeneron Pharmaceuticals Inc.
- 11.4.1 Regeneron Pharmaceuticals Inc. Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Products Offered
- 11.4.5 Regeneron Pharmaceuticals Inc. Recent Development
- 11.5 Bayer AG
- 11.5.1 Bayer AG Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer AG Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer AG Choroidal Neovascularization Products Offered
- 11.5.5 Bayer AG Recent Development
- 11.6 QLT Inc.
- 11.6.1 QLT Inc. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 QLT Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 QLT Inc. Choroidal Neovascularization Products Offered
- 11.6.5 QLT Inc. Recent Development
- 11.7 Sanwa Kagaku Kenkyusho Co. Ltd.
- 11.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Products Offered
- 11.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Development
- 11.8 Promedior Inc.
- 11.8.1 Promedior Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Promedior Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Promedior Inc. Choroidal Neovascularization Products Offered
- 11.8.5 Promedior Inc. Recent Development
- 11.9 Valeant Pharmaceuticals International Inc.
- 11.9.1 Valeant Pharmaceuticals International Inc. Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization Products Offered
- 11.9.5 Valeant Pharmaceuticals International Inc. Recent Development
- 11.10 Gilead Sciences Inc
- 11.10.1 Gilead Sciences Inc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Gilead Sciences Inc Choroidal Neovascularization Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Gilead Sciences Inc Choroidal Neovascularization Products Offered
- 11.10.5 Gilead Sciences Inc Recent Development
12 Future Forecast
- 12.1 Choroidal Neovascularization Market Forecast by Regions
- 12.1.1 Global Choroidal Neovascularization Sales Forecast by Regions 2019-2025
- 12.1.2 Global Choroidal Neovascularization Revenue Forecast by Regions 2019-2025
- 12.2 Choroidal Neovascularization Market Forecast by Product
- 12.2.1 Global Choroidal Neovascularization Sales Forecast by Product 2019-2025
- 12.2.2 Global Choroidal Neovascularization Revenue Forecast by Product 2019-2025
- 12.3 Choroidal Neovascularization Market Forecast by End User
- 12.4 North America Choroidal Neovascularization Forecast
- 12.5 Europe Choroidal Neovascularization Forecast
- 12.6 Asia Pacific Choroidal Neovascularization Forecast
- 12.7 Central & South America Choroidal Neovascularization Forecast
- 12.8 Middle East and Africa Choroidal Neovascularization Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Choroidal Neovascularization Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Choroidal Neovascularization . Industry analysis & Market Report on Choroidal Neovascularization is a syndicated market report, published as Global Choroidal Neovascularization Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Choroidal Neovascularization market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
